Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	189.25	196.81	29.16	99.92
Short-Term Investments	152.67	-	-	-
Cash & Short-Term Investments	341.92	196.81	29.16	99.92
Cash Growth	73.73%	574.99%	-70.82%	-
Other Current Assets	7.8	4.86	4.95	6.23
Total Current Assets	349.72	201.67	34.11	106.15
Net Property, Plant & Equipment	25.16	29.92	34.98	41.23
Long-Term Investments	18.11	-	-	-
Other Long-Term Assets	4.14	8.95	2.41	2.58
Total Assets	397.13	240.54	71.5	149.96
Accounts Payable	1.79	1.94	2.02	1.59
Accrued Expenses	15.97	14.1	9.81	14.87
Current Portion of Leases	4.8	4.63	4.49	4.32
Total Current Liabilities	22.56	20.67	16.32	20.78
Long-Term Debt	-	-	20.08	-
Long-Term Leases	18.51	22	25.05	27.73
Other Long-Term Liabilities	1.09	0.97	-	-
Total Long-Term Liabilities	19.61	22.97	45.13	27.73
Total Liabilities	42.16	43.64	61.45	48.51
Common Stock	0.05	0	0	0
Additional Paid-in Capital	844.35	47.24	21.84	12.81
Accumulated Other Comprehensive Income	0.11	-	-	-
Retained Earnings	-489.55	-358.43	-395.69	-295.27
Minority Interest	-	508.09	383.9	383.9
Shareholders' Equity	354.97	-311.18	-373.85	-282.46
Total Liabilities & Equity	397.13	240.54	71.5	149.96
Total Debt	23.31	26.63	49.62	32.06
Net Cash (Debt)	318.61	170.18	-20.47	67.86
Net Cash Growth	87.22%	-	-	-
Net Cash Per Share	7.41	62.33	-8.95	33.78
Book Value	354.97	-311.18	-373.85	-282.46
Book Value Per Share	8.26	-113.97	-163.40	-140.59
Tangible Book Value	354.97	-311.18	-373.85	-282.46
Tangible Book Value Per Share	8.26	-113.97	-163.40	-140.59

Updated Mar 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q